News and Press Releases
News articles and Press releases
Abarceo attended Biostock’s event in Stockholm
On September 23, BioStock's event Investing in Life Science 2025 took place in Stockholm. It was a day full of insights, inspiration, innovation and panel discussions. Abarceo's CEO Adam Bruce attended the event and presented Abarceo's development toward creating a...
Novel approach to treating type 2 diabetes
We are proud to present groundbreaking data at the 5th Swedish Diabetes Summit, revealing a novel approach to treating type 2 diabetes through VDAC1 oligomerization inhibitors. We share our exciting poster presented by our Principal Scientist Ruchi Jain and our...
Can we reverse diabetes? – Abarceo Pharma aims to develop the solution of the future
World Diabetes Day on November 14 raised awareness of diabetes as one of the greatest public health challenges of our time, along with the importance of ensuring access to adequate care for everyone affected. Claes Wollheim, founder of...
Investing in Life Science 2024 – Presentation
Adam Bruce, CEO & Chair of Abarceo Pharma, presents at Investing in Life Science - From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event,...
Investing in Life Science 2024 – Interview
BioStock’s Natasha Bank interviews Adam Bruce, CEO & Chair of Abarceo Pharma, at Investing in Life Science – From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the...